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http://dx.doi.org/10.1016/j.fjs.2013.Summary Recently, a metabolic shift between the increased cytoplasmic glycolysis and
decreased mitochondrial respiration in cellular energy production has been regarded as a bio-
logical hallmark for human cancers. As speculated by Warburg in the 1950s, respiratory com-
plexes (i.e., mitochondria in modern terminology) were impaired or suppressed in human
cancers, and such a defect may play an important role in the carcinogenesis and progression
of human cancer. To appraise the mitochondrial defect, several researchers paid considerable
attention to the role of mitochondrial DNA (mtDNA) alterations in multiple human cancers, and
some results showed clinical significance. Generally, the way to analyze mtDNA alterations is
mainly focused on the quantitative copy number changes and the qualitative displacement
loop (D-loop) mutations. Based on the heteroplasmic to homoplasmic D310 mutation of D-loop
and progressive increase of mtDNA copy number, the theory of cancer clonal expansion can be
well explained from the viewpoint of mtDNA alteration. In conclusion, the role of mtDNA insta-
bility might be a good biological marker to correlate with carcinogenesis, disease progression,
and drug resistance in several human cancers.
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Mitochondria, located in the cytoplasm, are the main or-
ganelles responsible for adenosine triphosphate (ATP) pro-
duction through the Krebs cycle (also known as citric acid
cycle or tricarboxylic acid cycle), electron transport chain,
and oxidative phosphorylation, to meet the energy de-
mands of human cells. As early as in the 1930s, Otto
Warburg, a German biochemist, found that human cancer
cells displayed an avid glucose uptake and modified glucose
metabolism to generate ATP, including increased lactate
fermentation in the cytoplasm and decreased respiration in
the “respiration complexes” (known in modern terminology
as the mitochondria) even if the oxygen supply is sufficient.
The theory of respiratory impairment (i.e., the mitochon-
drial dysfunction in human cancers) has been adopted since
the 1950s by Otto Warburg. Although the vast majority of
mitochondrial proteins (about 900) are encoded in the nu-
clear genome and imported into the mitochondria to
maintain the mitochondrial function, there are 13 poly-
peptides necessary for constitution of the electron trans-
port chain, and 22 tRNAs plus two rRNAs essential for the
translation of mitochondrial DNA (mtDNA) transcripts
encoded in the mitochondrial genome. To appraise the role
of mitochondrial dysfunction in human cancers, the analysis
of mtDNA alterations is indispensable. Herein, we will
discuss the role of mtDNA instability in human cancers.
2. Mitochondria and Warburg effect in human
cancers
Generally, 1 mol of glucose can generate approximately
36e38 mol of ATP, including 2 mol ATP from glycolysis in the
cytoplasm (oxygen independent) and 34e36 mol ATP from
oxidative phosphorylation in the mitochondria (oxygen
dependent), after a complete glucose metabolism. During
glycolysis, 1 mol glucose can be converted into 2 mol
pyruvate, which then enters the Krebs cycle through acetyl-
CoA for subsequent electron transport and oxidative phos-
phorylation in the mitochondria. However, under specific
conditions of either insufficient oxygen supply (e.g., mus-
cles undergoing prolonged exercise) or impaired mito-
chondria (e.g., sepsis), pyruvate is transiently reduced to
lactate by lactate dehydrogenase in the cytoplasm instead
of entering the mitochondria. This kind of modified glucose
metabolism is termed anaerobic glycolysis or lactate
fermentation, and only 2 mol ATP can be generated.1
In sharp contrast to the normal human cells, in addition
to the mitochondrial respiration, human cancer cells also
exhibit a profound glucose uptake to generate ATP through
lactate fermentation, even if the surrounding oxygen
supply is sufficient. This special phenomenon, was first
observed as early as in 1930s by a German biochemist, Otto
Warburg, and reported in the 1950s, it is now called the
Warburg effect.2e4 He contended that human cancer cells,
unlike normal human cells, can obtain ATP from both
oxidative phosphorylation in the mitochondria and lactate
fermentation in the cytoplasm with a shifting of decreased
ratio in oxidative phosphorylation and increased ratio in
lactate fermentation. This kind of metabolic shiftprompted Warburg to speculate that the respiratory
enzyme complexes (i.e., the mitochondria) in human can-
cer cells might be impaired or suppressed.2e5
3. Human mtDNA copy number
In human cells, mitochondria are distributed in the cellular
cytoplasm to form a mitochondrial network. The majority
of these mitochondria are connected to one another most
of the time.6 Generally speaking, each human cell contains
several hundreds to 1000 connected mitochondria, and
each mitochondrion has approximately 2e10 copies of
mtDNA. As a result, there are several thousand copies of
mtDNA molecules distributed in the cytoplasmic mito-
chondria in a human cell. The number of mtDNA copies in
normal human tissues is highly dynamic and varies widely
with different cell types and various physiological condi-
tions. Theoretically, the higher the energy demand, the
more mtDNA copies are present in the human cells.7
4. Structure of human mtDNA
Human mtDNA51 is located in the inner membrane of the
mitochondrion, and is a closed circular and double-
stranded DNA structure that contains a total of 16,569
base pairs (bp). The inner strand is called the light (L)
strand, and the outer strand is called the heavy (H) strand.7
As regards the entire human mtDNA, it consists of a non-
coding (also called D-loop) and a coding region, and
has been sequenced completely (L-strand, revised
Cambridge Reference Sequence, rCRS).8 The D-loop is
located from np 16024 through 16569, 1, and then 576
(16024/16569/1/576) with 1124 bp in size and is
essential for the regulation of mtDNA transcription and
replication. The replication origin of the H-strand and
transcription promoters of the L- and H-strands are all
located in the D-loop. However, the replication origin of the
L-strand is located in the coding region.7,9 The coding re-
gion is located between np 577 and np 16023 and is coding
for 13 polypeptides (12 in the H-strand and 1 in the
L-strand) that participate in the electron transport and
oxidative phosphorylation. Furthermore, the mtDNA is also
coding for two rRNAs (in H-strand) and a set of 22 tRNAs (14
in the H-strand and 8 in the L-strand) that are required for
protein synthesis in the mitochondria. All 13 mtDNA-
encoded polypeptides are required for the assembly of
respiratory enzyme complexes, including seven (ND1, ND2,
ND3, ND4, ND4L, ND5, and ND6, where ND denotes NADH
dehydrogenase) in Complex I, one (cytochrome b) in
Complex III, three (COX I, COX II, and COX III, where COX
denotes cytochrome c oxidase) in Complex IV, and two
(ATPase 6 and ATPase 8) in Complex V.8 Only ND6 is encoded
in the L-strand, and the other 12 polypeptides are encoded
in the H-strand. With the exception of 13 polypeptides,
approximately 90 polypeptides constituting the respiratory
enzyme complexes are encoded in nuclear DNA (nDNA). All
subunits of Complex II (succinate-coenzyme Q oxidoreduc-
tase) are totally nDNA-encoded. Although mitochondria
have their own genomes, all proteins required for the
regulation of mtDNA replication and transcription are
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chondrial transcription factor (TFAM) plays a pivotal role
because TFAM can bind to the D-loop to regulate the
replication and transcription of mtDNA for mitochondrial
biogenesis.9,125. Hypothesis of mtDNA instability in Warburg
effect
One of the most commonly adopted hypothesis to explain
the association between human mtDNA instability and
Warburg effect in human cancers is oxidative damage and
its vicious cycle. As we know, oxidative DNA damage has
been demonstrated to play an important role in the carci-
nogenesis of human cancers.13,14 Such an oxidative damage
in human mtDNA may cause a dysregulation of human
mtDNA with subsequent mitochondrial dysfunction.
Impaired mitochondrial function further initiates an
improper electron transport and an electron leak. The
leaking electron may cause another course of oxidative
mtDNA damage.15,16 Then, the vicious cycle is sustained in
human cancers and the Warburg effect follows. When dis-
cussing the mtDNA instability in human cancers, most re-
searchers paid attention to the quantitative mtDNA copy
number changes and the qualitative mtDNA D-loop muta-
tions, especially the D310 mutation, with their association
to clinicopathological parameters.6. Human mtDNA damage and mutation
In general, nDNA is inherited from parents with equal con-
tributions, and it is termed as heterozygotic condition. On
the contrary, human mtDNA is transmitted exclusively
through the maternal lineage with a single origin. Moreover,
the majority of mtDNA molecules in the human cells of the
postmitotic tissues of an individual are assumed to be iden-
tical at birth, and such a situation is termed as “homoplasmy
or homoplasmic condition.”7,17 Because of the following
characteristicsdabsence of introns, lack of histone protec-
tion, insufficient DNA repair systems, lower fidelity of DNA
polymerase gamma, and increased exposure to reactive ox-
ygen species inside the mitochondriadhuman mtDNA mole-
cules are far more susceptible to oxidative damage
compared to nDNA molecules.18e20 When the mutant or
damaged mtDNA variants coexist with the wild-type inborn
mtDNA, the pattern of homoplasmy is disrupted and is shifted
to the so-called “heteroplasmy or heteroplasmic condition.”
With regard to the entire mtDNA structure, damage oc-
curs much more easily in the D-loop region, especially in
the two hypervariable regions (HV1 at np 16024e16083 and
HV2 at np 57e372).21e24 Among various kinds of D-loop
damage, the D310 mutation (a hot spot in HV2) is the most
common one.25 Between np 303 and np 316 of the D-loop,
there is a poly-cytidine (PCT) tract with a thymidine
inserted at np 310 (50-C303CCCCCCT310CCCCCC316-30). As a
rule, the cytidine number after thymidine remains constant
as 6.26,27 However, the cytidine number prior to thymidine
is highly variable. Generally, the cytidine number prior to
the thymidine is seven26,27 (7-C, based on the rCRS), but
6-C, 8-C, and 9-C variants have also been reported.Variations of the cytidine number in the D-loop of mtDNA
between np 303 and np 309 is termed as D310 polymorphism
or D310 sequence variations.7. Changes of mtDNA copy number in human
cancers
The alterations of mtDNA copy number have been evalu-
ated in several human cancers. When compared to the
noncancerous counterparts, a decrease in mtDNA copy
numbers has been detected in lung cancer, hepatocellular
carcinoma, gastric cancer, and breast cancer.28e30 In an
analysis of 29 lung cancer tissues after neoadjuvant
chemotherapy, a decrease of mtDNA copy number was
associated with the progression of lung cancer.31 Further-
more, Wu et al29 demonstrated that the decrease of the
mtDNA copy number was related to an advanced-stage
gastric cancer. All the above findings indicated that the
decrease of the mtDNA copy number in human cancers
might cause a decrease of mitochondrial function. On the
contrary, a progressive increase of the mtDNA copy number
was noted in carcinogenesis, a spectrum among normal
mucosa, mild dysplasia, moderate dysplasia, severe
dysplasia, and invasive carcinoma of head and neck cancers
in smokers.32 Also, when compared to the noncancerous
counterpart, an increase of mtDNA copy number was found
in thoracic esophageal squamous cell carcinoma (TESCC)
and head and neck cancers, especially in those who smoked
cigarettes.33,34 In TESCC, the increase of the mtDNA copy
number from noncancerous esophageal mucosa to TESCC
and then metastatic lymph nodes were compatible with the
increase of 8-OHdG (8-hydroxyl-20-deoxyguanosine, a
marker of oxidative damage on guanine) accumulation in
mtDNA of the above tissues. Such an increase was supposed
to compensate for the damaged mtDNA to maintain mito-
chondrial function in proper order.35,36 In an in vitro cell line
study, it was demonstrated that the high mtDNA copy
numbers were associated with a higher invasive activity
in TESCC cell lines. Using the knockdown technique to
decrease the expression of TFAM, a pivotal protein involved
in mtDNA replication and transcription, the mtDNA copy
number of TESCC was significantly decreased and the inva-
sive activity was also suppressed.37 Regardless of the in-
crease or decrease of mtDNA copy number, these mixed
results among different human cancers suggested an alter-
ation in mitochondrial function.8. mtDNA mutation in human cancers
Several authors have evaluated not only the quantitative
change in mtDNA copy number, but also the qualitative
mtDNA D-loop mutations in human cancers. D-loop muta-
tions, including the D310 region, have been reported in
prostate cancer, head and neck cancer, lung cancer, breast
cancer, etc.24,29,30,38e43 Furthermore, the D-loop mutations
were reported to harbor clinicopathological significance in
lung cancer and breast cancer.24,30 As the D310 region is
located near the H-strand replication origin and binding side
of TFAM, whether D310 mutation is related to the change of
mtDNA copy number and mitochondrial biogenesis in human
74 C.-S. Lin, L.-S. Wangcancer remains obscured. However, several studies have
demonstrated that D310 is a good marker to trace cancer
cell clonal expansion.33,40,42,44 An analysis of 72 pairs of
TESCC revealed a homoplasmic to heteroplasmic mtDNA
D310 distribution from esophageal muscle to esophageal
mucosa, and a heteroplasmic to homoplasmic mtDNA D310
redistribution from esophageal nontumor mucosa to TESCC,
and then the metastatic lymph node, combined with an
increase of mtDNA copy number. This specific finding was
compatible with the theory of cancer clonal expansion.33,45
As a consequence, the effect of D310 mutations on bio-
energetic function of mitochondria in tumor tissues de-
serves to be further studied in the future.
9. Circulating mtDNA in human cancers
Recently, several investigators have also made great efforts
to appraise the alteration of circulating plasma or serum
mtDNA in several human cancers and evaluate their clinical
implications.46 An elevation of circulating mtDNA copy
number was noted in patients with urological malignancy,47
testicular germ cell cancer,48 and lung cancer after radio-
therapy.49 On the contrary, a decrease of circulating mtDNA
copy number was noted in breast cancer.50 At present, it is
difficult to investigate the sources of these circulating
mtDNA copies, and it is still unclear whether these alter-
ations are related to the shifting of cancer metabolism.
In conclusion, because of high susceptibility to oxidative
damage and participation in the mitochondrial respiration,
the analysis of mtDNA instability is a strategy of choice to
evaluate disease progression and drug resistance in human
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